February 12, 2018
2 min watch
Save
VIDEO: New class of therapies may offer neuroprotection, pressure lowering
SAN FRANCISCO ― At the Glaucoma 360: New Horizons Forum, Jeffrey L. Goldberg, MD, PhD, professor and chair of ophthalmology at the Byers Eye Institute at Stanford University, discusses new glaucoma therapies that show promise to not only lower IOP but also provide neuroprotection.